These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4026990)

  • 21. Effect of reduction and alkylation on structure and function of rabbit IgG antibody--II. Effects on classical pathway C3 convertase formation.
    Johnson BA; Hoffmann LG
    Mol Immunol; 1984 Jan; 21(1):77-87. PubMed ID: 6561390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoglobulin-mediated shifting of immune complexes to increased complement-dependent solubility and immunoadherence.
    Spycher MO; Späth PJ; Häsig A; Nydegger UE
    Mol Immunol; 1984 Jun; 21(6):497-505. PubMed ID: 6431266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the inactivation of IgM and IgG complement fixation sites by acid and base.
    Stollar BD; Stadecker MJ; Morecki S
    J Immunol; 1976 Oct; 117(4):1387-91. PubMed ID: 10334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired agglutination of IgM resulting from non-enzymatic glycation in diabetes mellitus.
    Hammes HP; Kiefel V; Laube H; Federlin K
    Diabetes Res Clin Pract; 1990 Apr; 9(1):37-42. PubMed ID: 2351038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1.
    Füst G; Medgyesi GA; Rajnavölgyi E; Csécsi-Nagy M; Czikora K; Gergely J
    Immunology; 1978 Dec; 35(6):873-84. PubMed ID: 104923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced glycation end products in diabetic corneas.
    Kaji Y; Usui T; Oshika T; Matsubara M; Yamashita H; Araie M; Murata T; Ishibashi T; Nagai R; Horiuchi S; Amano S
    Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):362-8. PubMed ID: 10670463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):575-82. PubMed ID: 4536807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IgG glycation and function during continuous ambulatory peritoneal dialysis.
    Davin JC; Bouts AH; Krediet RT; van der Weel M; Weening RS; Groothoff J; Out TA
    Nephrol Dial Transplant; 1997 Feb; 12(2):310-4. PubMed ID: 9132651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The etiologic agents of varicella and herpes zoster; serologic studies with the viruses as propagated in vitro.
    WELLER TH; WITTON HM
    J Exp Med; 1958 Dec; 108(6):869-90. PubMed ID: 13598817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement fixation by pemphigus antibody. I. In vitro fixation to organ and tissue culture skin.
    Kawana S; Janson M; Jordon RE
    J Invest Dermatol; 1984 May; 82(5):506-10. PubMed ID: 6439783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative immunology of immune hemolytic anemia. I. The fixation of C1 by autoimmune antibody and heterologous anti-IgG antibody.
    Rosse WF
    J Clin Invest; 1971 Apr; 50(4):727-33. PubMed ID: 4995527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humoral immunity in type 1 diabetes mellitus: a prospective study.
    Borsey DQ; Di Mario U; Irvine WJ; Gray RS; Guy K; Weston J; Peutherer J; Duncan LJ
    J Clin Lab Immunol; 1983 May; 11(1):9-15. PubMed ID: 6876143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.
    Brown EJ; Hosea SW; Hammer CH; Burch CG; Frank MM
    J Clin Invest; 1982 Jan; 69(1):85-98. PubMed ID: 7054244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of serum antibody titers against varicella zoster virus in Japanese patients with herpes zoster.
    Miyachi M; Ihara H; Imafuku S
    J Dermatol; 2017 Jun; 44(6):656-659. PubMed ID: 28012212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The low ionic strength reaction of human blood: relationship between the binding of serum immunoglobulin and complement of red blood cells and surface charge of the cells.
    Hsu TC; Steinberg J; LeDoux R; Sawitsky A
    Br J Haematol; 1979 Jul; 42(3):403-15. PubMed ID: 38828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoglobulin glycation with fructose: a comparative study.
    Jairajpuri DS; Fatima S; Saleemuddin M
    Clin Chim Acta; 2007 Mar; 378(1-2):86-92. PubMed ID: 17173886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced antiglobulin-mediated neutralization of herpes simplex virus-IgG complexes by complement and heterologous anti-immunoglobulin.
    Shivers JC; Daniels CA
    Arch Virol; 1979; 59(1-2):89-97. PubMed ID: 218539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polyclonal antibodies inhibit the glycation-induced inactivation of bovine Cu,Zn-superoxide dismutase.
    Jabeen R; Saleemuddin M
    Biotechnol Appl Biochem; 2006 Jan; 43(Pt 1):49-53. PubMed ID: 16086668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycation of platelet protein in diabetes mellitus: lack of correlation with platelet function.
    Yatscoff RW; Mehta A; Gerrard JM; Thliveris J
    Clin Biochem; 1987 Oct; 20(5):359-63. PubMed ID: 3690834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific immunoglobulin responses after varicella and herpes zoster.
    Cradock-Watson JE; Ridehalgh MK; Bourne MS
    J Hyg (Lond); 1979 Apr; 82(2):319-36. PubMed ID: 219110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.